SB 628

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for misbranding.

In committee Last action April 11, 2025: Referred to Health & Human Services

Official bill page and text: palegis.us

Sponsors 11

Prime sponsor: Amanda Cappelletti
Cosponsors (10): Art Haywood, Carolyn Comitta, Christine Tartaglione, Jay Costa, John Kane, Judith Schwank, Katie Muth, Nikil Saval, Rosemary Brown, Tracy Pennycuick

Status

In committee as of April 11, 2025. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 1

Date	Chamber	Action
April 11, 2025	Senate	Referred to Health & Human Services

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Open States API v3 (Plural Policy): https://v3.openstates.org/ — copied November 2, 2026

Pennsylvania General Assembly: https://www.palegis.us/legislation/bills — copied November 2, 2026

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.